Mifepristona (Portuguese Wikipedia)

«Abortion Foes To Boycott Drugs (Altace) Made By RU-486 Manufacturer». The Virginia Pilot. 8 de julho de 1994. Consultado em 15 de setembro de 2006. Arquivado do original em 20 de fevereiro de 2008

australianprescriber.com

Healy D (2009). «Mifepristone: an overview for Australian practice». Australian Prescriber. 32 (6): 152–154. Consultado em 25 de agosto de 2015. Arquivado do original em 27 de julho de 2011

bbc.co.uk

news.bbc.co.uk

«Abortion pill approved in Italy». BBC News. 31 de julho de 2009. Consultado em 31 de julho de 2009

betterhealth.vic.gov.au

«Abortion pill - RU486 (mifepristone)». Better Health Channel Victoria. Julho de 2010. Consultado em 15 de dezembro de 2010. Arquivado do original em 14 de agosto de 2010

books.google.com

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.

budapesttimes.hu

«Abortion pill sparks bitter protest». The Budapest Times. 19 de setembro de 2005. Consultado em 16 de setembro de 2006

cathnews.com

«Catholic and Evangelical students join Muslims in RU-486 fight». Catholic News. 9 de fevereiro de 2006. Consultado em 18 de setembro de 2006. Arquivado do original em 27 de outubro de 2006

cbc.ca

«RU-486 abortion pill approved by Health Canada». Consultado em 30 de julho de 2015

cbctrust.com

."Results of the Canadian trials of RU486, the 'Abortion Pill'." (n.d.). Retrieved 2006-12-08.

cdc.gov

Pazol, Karen; Zane, Suzanne B.; Parker, Wilda, Y.; Hall, Laura R.; Gamble, Sonya B.; Hamdan, Saeed; Berg, Cynthia; Cook, Douglas A.; Division of Reproductive Health (25 de fevereiro de 2011). «Abortion surveillance — United States, 2007» (PDF). MMWR Surveill Summ. 60 (1): 1–44. PMID 21346710

chicagotribune.com

articles.chicagotribune.com

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.

christianitytoday.com

Stan Guthrie (11 de junho de 2001). «Counteroffensive Launched on RU-486». Christianity Today. Consultado em 20 de setembro de 2006

clinicaltrials.gov

«A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness». ClinicalTrials.gov. U.S. National Institutes of Health. Junho de 2008 Retrieved on November 7, 2008.

cnn.com

Nancy Gibbs (2 de outubro de 2000). «The Pill Arrives». Cnn.com. Consultado em 20 de setembro de 2006

dh.gov.uk

Department of Health (25 de maio de 2010). «Abortion statistics, England and Wales: 2009». Department of Health (United Kingdom). Consultado em 9 de junho de 2010

dkma.dk

«The abortion pill Mifegyne tested for adverse reactions». Danish Medicines Agency. 27 de julho de 2005. Consultado em 20 de setembro de 2006 ^{[ligação inativa]}

doi.org

dx.doi.org

Peter Gallagher, Navdeep Malik, James Newham, Allan H Young, Nicol Ferrier, Paul Mackin (2008). «Antiglucocorticoid treatments for mood disorders.». Cochrane Database Syst. Review. doi:10.1002/14651858.CD005168.pub2. Consultado em 25 de agosto de 2015. Arquivado do original em 22 de março de 2015
Spitz IM, Bardin CW, Benton L, Robbins A (abril de 1998). «Early pregnancy termination with mifepristone and misoprostol in the United States». N. Engl. J. Med. 338 (18): 1241–7. PMID 9562577. doi:10.1056/NEJM199804303381801
Piaggio G, von Hertzen H, Heng Z, Bilian X, Cheng L (dezembro de 2003). «Meta-analyses of randomized trials comparing different doses of mifepristone in emergency contraception». Contraception. 68 (6): 447–52. PMID 14698075. doi:10.1016/S0010-7824(03)00142-2
Gemzell-Danielsson K, Marions L (2004). «Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception». Hum. Reprod. Update. 10 (4): 341–8. PMID 15192056. doi:10.1093/humupd/dmh027
Flexner C (dezembro de 2007). «HIV drug development: the next 25 years». Nat Rev Drug Discov. 6 (12): 959–66. PMID 17932493. doi:10.1038/nrd2336
Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM (2005). «Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications». Hum Reprod Update. 11 (3): 293–307. PMID 15790602. doi:10.1093/humupd/dmi002
Tang OS, Ho PC (2006). «Clinical applications of mifepristone». Gynecol Endocrinol. 22 (12): 655–9. PMID 17162706. doi:10.1080/09513590601005946
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (outubro de 2001). «Rapid reversal of psychotic depression using mifepristone». J Clin Psychopharmacol. 21 (5): 516–21. PMID 11593077. doi:10.1097/00004714-200110000-00009
Golier JA, Caramanica K, Demaria R, Yehuda R (2012). «A Pilot Study of Mifepristone in Combat-Related PTSD». Depress Res Treat. 2012. 393251 páginas. PMC 3348629. PMID 22611490. doi:10.1155/2012/393251
Clark K, Ji H, Feltovich H, Janowski J, Carroll C, Chien EK (maio de 2006). «Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events». Am. J. Obstet. Gynecol. 194 (5): 1391–8. PMID 16647925. doi:10.1016/j.ajog.2005.11.026
Lawton BA, Rose SB, Shepherd J (abril de 2006). «Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion». Contraception. 73 (4): 431–2. PMID 16531180. doi:10.1016/j.contraception.2005.09.003
Gary MM, Harrison DJ (fevereiro de 2006). «Analysis of severe adverse events related to the use of mifepristone as an abortifacient». Ann Pharmacother. 40 (2): 191–7. PMID 16380436. doi:10.1345/aph.1G481
Orioli IM, Castilla EE (abril de 2000). «Epidemiological assessment of misoprostol teratogenicity». BJOG. 107 (4): 519–23. PMID 10759272. doi:10.1111/j.1471-0528.2000.tb13272.x
Fiala C, Gemzel-Danielsson K (julho de 2006). «Review of medical abortion using mifepristone in combination with a prostaglandin analogue». Contraception. 74 (1): 66–86. PMID 16781264. doi:10.1016/j.contraception.2006.03.018
Heikinheimo O, Kekkonen R, Lahteenmaki P (2003). «The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action». Contraception. 68 (6): 421–6. PMID 14698071. doi:10.1016/S0010-7824(03)00077-5
Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.
Behl C, Trapp T, Skutella T, Holsboer F (maio de 1997). «Protection against oxidative stress-induced neuronal cell death--a novel role for RU486». Eur. J. Neurosci. 9 (5): 912–20. PMID 9182944. doi:10.1111/j.1460-9568.1997.tb01442.x
Ghoumari AM, Dusart I, El-Etr M, Tronche F, Sotelo C, Schumacher M, Baulieu EE (junho de 2003). «Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum». Proc. Natl. Acad. Sci. U.S.A. 100 (13): 7953–8. PMC 164694. PMID 12810951. doi:10.1073/pnas.1332667100
Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (agosto de 2004). «Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder». Neuropsychopharmacology. 29 (8): 1538–45. PMID 15127079. doi:10.1038/sj.npp.1300471
Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, Young AH, Ferrier IN (dezembro de 2012). «A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression». Biol. Psychiatry. 72 (11): 943–9. PMID 22770649. doi:10.1016/j.biopsych.2012.05.029
Teutsch, Georges (24 de novembro de 1989). «RU 486 development». Science. 246 (4933): 985. PMID 2587990. doi:10.1126/science.2587990
Cherfas, J (24 de novembro de 1989). «Dispute surfaces over paternity of RU 486». Science. 246 (4933): 994. PMID 2587988. doi:10.1126/science.2587988
Philibert, D; Teutsch, G (9 de fevereiro de 1990). «RU 486 development». Science. 246 (4943): 622. PMID 2300819. doi:10.1126/science.2300819
Ulmann, A; Teutsch, G; Philibert, D (junho de 1990). «RU 486». Scientific American. 262 (6): 42–8. PMID 2343294. doi:10.1038/scientificamerican0690-42
Teutsch, G.; Deraedt, R.; Philibert, D. (1993). «Mifepristone». In: Lednicer, Daniel (ed.). Chronicles of drug discovery, Vol. 3. Washington, DC: American Chemical Society. pp. 1–43. ISBN 0-8412-2523-0
Teutsch, G; Philibert, D (junho de 1994). «History and perspectives of antiprogestins from the chemist's point of view». Human Reprod. 9 (Suppl 1): 12–31. PMID 7962457. doi:10.1093/humrep/9.suppl_1.12
Sittig, Marshall (ed.), ed. (2007). «Mifepristone». Pharmaceutical manufacturing encyclopedia 3rd ed. Norwich, NY: William Andrew Publishing. pp. 2307–2310. ISBN 1-60119-339-4
patent 5254836, Okada, Yuuji; Kobayashi, Toshihiko; Sasabe, Hiroshi; Aoki, Yoshimitsu; Nishizawa, Makoto; Endo, Shunji, "Method of arc welding with a ferrite stainless steel welding rod", publicado 19/10/1993 assigned to Roussel Uclaf
Bloomberg News (9 de abril de 1997). «Pill for abortion ends production». The New York Times. p. D2
Jouzaitis, Carol (9 de abril de 1997). «Abortion pill maker bows to boycott heat; German firm gives up RU-486 patent; little impact likely in U.S.». Chicago Tribune. p. 4
Lavin, Douglas (9 de abril de 1997). «Hoechst will stop making abortion pill». The Wall Street Journal. p. A3
(18 de abril de 1997). «Roussel-Uclaf to transfer RU 486 rights». Reprod Freedom News. 6 (7): 8. PMID 12292550
Dorozynski, Alexander (19 de abril de 1997). «Boycott threat forces French company to abandon RU486». BMJ. 314 (7088): 1150. PMC 2126515. PMID 9146386. doi:10.1136/bmj.314.7088.1145m
Klitsch M. November–December 1991. «Antiprogestins and the abortion controversy: a progress report». Fam Plann Perspect. 23 (6): 275–82. JSTOR 2135779. PMID 1786809. doi:10.2307/2135779
Jones, Rachel K.; Kooistra, Kathryn (março de 2011). «Abortion incidence and access to services in the United States, 2008» (PDF). Perspect Sex Reprod Health. 43 (1): 41–50. PMID 21388504. doi:10.1363/4304111
Stein, Rob (11 de janeiro de 2011). «Decline in U.S. abortion rate stalls». The Washington Post. p. A3
Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa (9 de julho de 2009). «Rates of serious infection after changes in regimens for medical abortion» (PDF). New England Journal of Medicine. 361 (2): 145–151. PMC 3568698. PMID 19587339. doi:10.1056/NEJMoa0809146
Allday, Erin (9 de julho de 2009). «Change cuts infections linked to abortion pill». San Francisco Chronicle. p. A1
Christin-Maitre, S., Bouchard, P., Spitz, I. M. (2000). «Medical termination of pregnancy». New England Journal of Medicine. 342 (13): 946–56. PMID 10738054. doi:10.1056/NEJM200003303421307
Stojnic J, et al. (2006). «Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro». Vojnosanitetski pregled. Military-medical and pharmaceutical review. 63 (6): 558–63. PMID 16796021. doi:10.2298/VSP0606558S
Sparrow MJ (2004). «A woman's choice». Aust NZ J Obstet Gynaecol. 44 (2): 88–92. PMID 15089829. doi:10.1111/j.1479-828X.2004.00190.x
Ganatra B, Bygdeman M, Nguyen DV, Vu ML, Phan BT (2004). «From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam». Reprod Health Matters. 12 (24): 105–13. PMID 15938163. doi:10.1016/S0968-8080(04)24022-8
Hajri S (2004). «Medication abortion: the Tunisian experience». Afr J Reprod Health. 8 (1): 63–9. JSTOR 3583307. PMID 15487615. doi:10.2307/3583307

earlyoptionpill.com

Danco Laboratories (19 de julho de 2005). «Mifeprex U.S. prescribing information» (PDF). Consultado em 9 de março de 2007. Arquivado do original (PDF) em 7 de janeiro de 2007

espacenet.com

worldwide.espacenet.com

Teutsch, Georges (24 de novembro de 1989). «RU 486 development». Science. 246 (4933): 985. PMID 2587990. doi:10.1126/science.2587990
Cherfas, J (24 de novembro de 1989). «Dispute surfaces over paternity of RU 486». Science. 246 (4933): 994. PMID 2587988. doi:10.1126/science.2587988
Philibert, D; Teutsch, G (9 de fevereiro de 1990). «RU 486 development». Science. 246 (4943): 622. PMID 2300819. doi:10.1126/science.2300819
Ulmann, A; Teutsch, G; Philibert, D (junho de 1990). «RU 486». Scientific American. 262 (6): 42–8. PMID 2343294. doi:10.1038/scientificamerican0690-42
Teutsch, G.; Deraedt, R.; Philibert, D. (1993). «Mifepristone». In: Lednicer, Daniel (ed.). Chronicles of drug discovery, Vol. 3. Washington, DC: American Chemical Society. pp. 1–43. ISBN 0-8412-2523-0
Teutsch, G; Philibert, D (junho de 1994). «History and perspectives of antiprogestins from the chemist's point of view». Human Reprod. 9 (Suppl 1): 12–31. PMID 7962457. doi:10.1093/humrep/9.suppl_1.12
Sittig, Marshall (ed.), ed. (2007). «Mifepristone». Pharmaceutical manufacturing encyclopedia 3rd ed. Norwich, NY: William Andrew Publishing. pp. 2307–2310. ISBN 1-60119-339-4
patent 5254836, Okada, Yuuji; Kobayashi, Toshihiko; Sasabe, Hiroshi; Aoki, Yoshimitsu; Nishizawa, Makoto; Endo, Shunji, "Method of arc welding with a ferrite stainless steel welding rod", publicado 19/10/1993 assigned to Roussel Uclaf

expresshealthcaremgmt.com

«Mifepristone can be sold only to approved MTP Centres: Rajasthan State HRC». Indian Express Health Care Management. 2000. Consultado em 25 de agosto de 2015. Arquivado do original em 24 de janeiro de 2012

fda.gov

FDA approves Korlym for patients with endogenous Cushing’s syndrome, Food & Drug Administration, February 17, 2012, Retrieved 2014-01-18
«Mifeprex label» (PDF). FDA. 19 de julho de 2005. Consultado em 22 de agosto de 2006. Cópia arquivada (PDF) em 28 de junho de 2006
«FDA approval letter for Mifepristone». FDA. 28 de setembro de 2000. Consultado em 16 de setembro de 2006. Cópia arquivada em 29 de agosto de 2006
Woodcock, Janet (12 de maio de 2006). «Testimony on RU-486». Committee on Government Reform, House of Representatives. FDA. Consultado em 19 de agosto de 2006. Cópia arquivada em 27 de setembro de 2006
«FDA Approves Mifepristone for the Termination of Early Pregnancy». FDA press release/U.S. Gov. 2000. Consultado em 27 de abril de 2009. Cópia arquivada em 10 de setembro de 2006

fiercebiotech.com

Damian Gard for Fierce Biotech. May 7, 2014. Corcept tanks as depression drug comes up short in Phase III

findarticles.com

John L. Allen (12 de fevereiro de 1999). «Abortion debates rock Germany: introduction of abortion pill exacerbates controversy». National Catholic Reporter. Consultado em 14 de setembro de 2006

fnsa.org

Paige Comstock Cunningham, Leanne McCoy, Clarke D. Ferguson (28 de fevereiro de 1995). «Citizen Petition to the U.S. Food and Drug Administration». Americans United for Life. Consultado em 20 de setembro de 2006

frc.org

downloads.frc.org

«Mifepristone U.S. Postmarketing Adverse Events Summary through 04/30/2011» (PDF). Consultado em 14 de novembro de 2011

guttmacher.org

Jones, Rachel K.; Kooistra, Kathryn (março de 2011). «Abortion incidence and access to services in the United States, 2008» (PDF). Perspect Sex Reprod Health. 43 (1): 41–50. PMID 21388504. doi:10.1363/4304111
Stein, Rob (11 de janeiro de 2011). «Decline in U.S. abortion rate stalls». The Washington Post. p. A3

gynuity.org

(4 de novembro de 2009). «List of mifepristone approval» (PDF). New York: Gynuity Health Projects. Consultado em 25 de agosto de 2015. Arquivado do original (PDF) em 26 de julho de 2011
(4 de novembro de 2009). «Map of mifepristone approval» (PDF). New York: Gynuity Health Projects. Consultado em 11 de junho de 2010. Arquivado do original (PDF) em 26 de julho de 2011

ich.org

«www.ich.org» (PDF)

ipas.org

«Medical Abortion-Implications for Africa» (PDF). Ipas. 2003. Consultado em 16 de setembro de 2006. Arquivado do original (PDF) em 28 de setembro de 2007

isdscotland.org

ISD Scotland (25 de maio de 2010). «Abortion Statistics, year ending December 2009». Information Services Division (ISD), NHS National Services Scotland. Consultado em 9 de junho de 2010

jamanetwork.com

jama.jamanetwork.com

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.

jstor.org

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.
Klitsch M. November–December 1991. «Antiprogestins and the abortion controversy: a progress report». Fam Plann Perspect. 23 (6): 275–82. JSTOR 2135779. PMID 1786809. doi:10.2307/2135779
Hajri S (2004). «Medication abortion: the Tunisian experience». Afr J Reprod Health. 8 (1): 63–9. JSTOR 3583307. PMID 15487615. doi:10.2307/3583307

mariestopes.org.au

«Marie Stopes International Australia - Medical Abortion». 2010. Consultado em 15 de dezembro de 2010. Arquivado do original em 22 de novembro de 2010

medicationabortion.com

«Medication Abortion». Ibis. 2002. Consultado em 19 de setembro de 2006

medicines.org.uk

emc.medicines.org.uk

Exelgyn Laboratories (fevereiro de 2006). «Mifegyne UK Summary of Product Characteristics (SPC)». Consultado em 9 de março de 2007

nap.edu

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.

nejm.org

content.nejm.org

Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa (9 de julho de 2009). «Rates of serious infection after changes in regimens for medical abortion» (PDF). New England Journal of Medicine. 361 (2): 145–151. PMC 3568698. PMID 19587339. doi:10.1056/NEJMoa0809146
Allday, Erin (9 de julho de 2009). «Change cuts infections linked to abortion pill». San Francisco Chronicle. p. A1

nih.gov

ncbi.nlm.nih.gov

Gallagher P, Young AH (março de 2006). «Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications». Neuropsychiatr Dis Treat. 2 (1): 33–42. PMC 2671735. PMID 19412444
Spitz IM, Bardin CW, Benton L, Robbins A (abril de 1998). «Early pregnancy termination with mifepristone and misoprostol in the United States». N. Engl. J. Med. 338 (18): 1241–7. PMID 9562577. doi:10.1056/NEJM199804303381801
Piaggio G, von Hertzen H, Heng Z, Bilian X, Cheng L (dezembro de 2003). «Meta-analyses of randomized trials comparing different doses of mifepristone in emergency contraception». Contraception. 68 (6): 447–52. PMID 14698075. doi:10.1016/S0010-7824(03)00142-2
Wertheimer RE (novembro de 2000). «Emergency postcoital contraception». Am Fam Physician. 62 (10): 2287–92. PMID 11126855
Gemzell-Danielsson K, Marions L (2004). «Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception». Hum. Reprod. Update. 10 (4): 341–8. PMID 15192056. doi:10.1093/humupd/dmh027
Flexner C (dezembro de 2007). «HIV drug development: the next 25 years». Nat Rev Drug Discov. 6 (12): 959–66. PMID 17932493. doi:10.1038/nrd2336
Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM (2005). «Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications». Hum Reprod Update. 11 (3): 293–307. PMID 15790602. doi:10.1093/humupd/dmi002
Tang OS, Ho PC (2006). «Clinical applications of mifepristone». Gynecol Endocrinol. 22 (12): 655–9. PMID 17162706. doi:10.1080/09513590601005946
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (outubro de 2001). «Rapid reversal of psychotic depression using mifepristone». J Clin Psychopharmacol. 21 (5): 516–21. PMID 11593077. doi:10.1097/00004714-200110000-00009
Golier JA, Caramanica K, Demaria R, Yehuda R (2012). «A Pilot Study of Mifepristone in Combat-Related PTSD». Depress Res Treat. 2012. 393251 páginas. PMC 3348629. PMID 22611490. doi:10.1155/2012/393251
Clark K, Ji H, Feltovich H, Janowski J, Carroll C, Chien EK (maio de 2006). «Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events». Am. J. Obstet. Gynecol. 194 (5): 1391–8. PMID 16647925. doi:10.1016/j.ajog.2005.11.026
Lawton BA, Rose SB, Shepherd J (abril de 2006). «Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion». Contraception. 73 (4): 431–2. PMID 16531180. doi:10.1016/j.contraception.2005.09.003
Gary MM, Harrison DJ (fevereiro de 2006). «Analysis of severe adverse events related to the use of mifepristone as an abortifacient». Ann Pharmacother. 40 (2): 191–7. PMID 16380436. doi:10.1345/aph.1G481
Orioli IM, Castilla EE (abril de 2000). «Epidemiological assessment of misoprostol teratogenicity». BJOG. 107 (4): 519–23. PMID 10759272. doi:10.1111/j.1471-0528.2000.tb13272.x
Fiala C, Gemzel-Danielsson K (julho de 2006). «Review of medical abortion using mifepristone in combination with a prostaglandin analogue». Contraception. 74 (1): 66–86. PMID 16781264. doi:10.1016/j.contraception.2006.03.018
Heikinheimo O, Kekkonen R, Lahteenmaki P (2003). «The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action». Contraception. 68 (6): 421–6. PMID 14698071. doi:10.1016/S0010-7824(03)00077-5
Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.
Behl C, Trapp T, Skutella T, Holsboer F (maio de 1997). «Protection against oxidative stress-induced neuronal cell death--a novel role for RU486». Eur. J. Neurosci. 9 (5): 912–20. PMID 9182944. doi:10.1111/j.1460-9568.1997.tb01442.x
Ghoumari AM, Dusart I, El-Etr M, Tronche F, Sotelo C, Schumacher M, Baulieu EE (junho de 2003). «Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum». Proc. Natl. Acad. Sci. U.S.A. 100 (13): 7953–8. PMC 164694. PMID 12810951. doi:10.1073/pnas.1332667100
Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (agosto de 2004). «Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder». Neuropsychopharmacology. 29 (8): 1538–45. PMID 15127079. doi:10.1038/sj.npp.1300471
Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, Young AH, Ferrier IN (dezembro de 2012). «A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression». Biol. Psychiatry. 72 (11): 943–9. PMID 22770649. doi:10.1016/j.biopsych.2012.05.029
Baulieu, Étienne-Émile; Rosenblum, Mort (1991). The "abortion pill" : RU-486, a woman's choice. New York: Simon & Schuster. ISBN 0-671-73816-X
Lader, Lawrence (1991). RU 486 : the pill that could end the abortion wars and why American women don't have it. Reading: Addison-Wesley. ISBN 0-201-57069-6
Villaran, Gilda (1998). «RU 486». In: Schlegelmilch, Bodo B. (ed.). Marketing ethics : an international perspective. London: Thomson Learning. pp. 155–190. ISBN 1-86152-191-X
Ulmann, André (2000). «The development of mifepristone: a pharmaceutical drama in three acts». J Am Med Womens Assoc. 55 (3 Suppl): 117–20. PMID 10846319
Teutsch, Georges (24 de novembro de 1989). «RU 486 development». Science. 246 (4933): 985. PMID 2587990. doi:10.1126/science.2587990
Cherfas, J (24 de novembro de 1989). «Dispute surfaces over paternity of RU 486». Science. 246 (4933): 994. PMID 2587988. doi:10.1126/science.2587988
Philibert, D; Teutsch, G (9 de fevereiro de 1990). «RU 486 development». Science. 246 (4943): 622. PMID 2300819. doi:10.1126/science.2300819
Ulmann, A; Teutsch, G; Philibert, D (junho de 1990). «RU 486». Scientific American. 262 (6): 42–8. PMID 2343294. doi:10.1038/scientificamerican0690-42
Teutsch, G.; Deraedt, R.; Philibert, D. (1993). «Mifepristone». In: Lednicer, Daniel (ed.). Chronicles of drug discovery, Vol. 3. Washington, DC: American Chemical Society. pp. 1–43. ISBN 0-8412-2523-0
Teutsch, G; Philibert, D (junho de 1994). «History and perspectives of antiprogestins from the chemist's point of view». Human Reprod. 9 (Suppl 1): 12–31. PMID 7962457. doi:10.1093/humrep/9.suppl_1.12
Sittig, Marshall (ed.), ed. (2007). «Mifepristone». Pharmaceutical manufacturing encyclopedia 3rd ed. Norwich, NY: William Andrew Publishing. pp. 2307–2310. ISBN 1-60119-339-4
patent 5254836, Okada, Yuuji; Kobayashi, Toshihiko; Sasabe, Hiroshi; Aoki, Yoshimitsu; Nishizawa, Makoto; Endo, Shunji, "Method of arc welding with a ferrite stainless steel welding rod", publicado 19/10/1993 assigned to Roussel Uclaf
Eder, Richard (20 de abril de 1982). «Birth control: 4-day pill is promising in early test». The New York Times. p. C1
Herrmann, Walter; Wyss, Rolf; Riondel, Anne; Philibert, Daniel; Teutsch, Georges; Sakiz, Edouard; Baulieu, Étienne-Émile (17 de maio de 1982). «The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy». C R Seances Acad Sci III. 294 (18): 933–8. PMID 6814714
Smith, W. (setembro de 1991). «Great Britain second country to allow use of RU-486». Plan Parent Eur. 20 (2): 20. PMID 12284548
(dezembro de 1992). «RU 486 licensed in Sweden». IPPF Med Bull. 26 (6): 6. PMID 12346922
Bloomberg News (9 de abril de 1997). «Pill for abortion ends production». The New York Times. p. D2
Jouzaitis, Carol (9 de abril de 1997). «Abortion pill maker bows to boycott heat; German firm gives up RU-486 patent; little impact likely in U.S.». Chicago Tribune. p. 4
Lavin, Douglas (9 de abril de 1997). «Hoechst will stop making abortion pill». The Wall Street Journal. p. A3
(18 de abril de 1997). «Roussel-Uclaf to transfer RU 486 rights». Reprod Freedom News. 6 (7): 8. PMID 12292550
Dorozynski, Alexander (19 de abril de 1997). «Boycott threat forces French company to abandon RU486». BMJ. 314 (7088): 1150. PMC 2126515. PMID 9146386. doi:10.1136/bmj.314.7088.1145m
Klitsch M. November–December 1991. «Antiprogestins and the abortion controversy: a progress report». Fam Plann Perspect. 23 (6): 275–82. JSTOR 2135779. PMID 1786809. doi:10.2307/2135779
Pazol, Karen; Zane, Suzanne B.; Parker, Wilda, Y.; Hall, Laura R.; Gamble, Sonya B.; Hamdan, Saeed; Berg, Cynthia; Cook, Douglas A.; Division of Reproductive Health (25 de fevereiro de 2011). «Abortion surveillance — United States, 2007» (PDF). MMWR Surveill Summ. 60 (1): 1–44. PMID 21346710
Jones, Rachel K.; Kooistra, Kathryn (março de 2011). «Abortion incidence and access to services in the United States, 2008» (PDF). Perspect Sex Reprod Health. 43 (1): 41–50. PMID 21388504. doi:10.1363/4304111
Stein, Rob (11 de janeiro de 2011). «Decline in U.S. abortion rate stalls». The Washington Post. p. A3
Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa (9 de julho de 2009). «Rates of serious infection after changes in regimens for medical abortion» (PDF). New England Journal of Medicine. 361 (2): 145–151. PMC 3568698. PMID 19587339. doi:10.1056/NEJMoa0809146
Allday, Erin (9 de julho de 2009). «Change cuts infections linked to abortion pill». San Francisco Chronicle. p. A1
Christin-Maitre, S., Bouchard, P., Spitz, I. M. (2000). «Medical termination of pregnancy». New England Journal of Medicine. 342 (13): 946–56. PMID 10738054. doi:10.1056/NEJM200003303421307
Stojnic J, et al. (2006). «Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro». Vojnosanitetski pregled. Military-medical and pharmaceutical review. 63 (6): 558–63. PMID 16796021. doi:10.2298/VSP0606558S
Sparrow MJ (2004). «A woman's choice». Aust NZ J Obstet Gynaecol. 44 (2): 88–92. PMID 15089829. doi:10.1111/j.1479-828X.2004.00190.x
Ulmann A (2000). «The development of mifepristone: a pharmaceutical drama in three acts». J Am Med Women's Assoc. 55 (3 Suppl): 117–20. PMID 10846319
Wu S (2000). «Medical abortion in China». J Am Med Women's Assoc. 55 (3 Suppl): 197–9, 204. PMID 10846339
Tsai EM, Yang CH, Lee JN (2002). «Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women». J Formos Med Assoc. 101 (4): 277–82. PMID 12101864
Ganatra B, Bygdeman M, Nguyen DV, Vu ML, Phan BT (2004). «From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam». Reprod Health Matters. 12 (24): 105–13. PMID 15938163. doi:10.1016/S0968-8080(04)24022-8
Hajri S (2004). «Medication abortion: the Tunisian experience». Afr J Reprod Health. 8 (1): 63–9. JSTOR 3583307. PMID 15487615. doi:10.2307/3583307

nytimes.com

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.
Eder, Richard (20 de abril de 1982). «Birth control: 4-day pill is promising in early test». The New York Times. p. C1
Herrmann, Walter; Wyss, Rolf; Riondel, Anne; Philibert, Daniel; Teutsch, Georges; Sakiz, Edouard; Baulieu, Étienne-Émile (17 de maio de 1982). «The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy». C R Seances Acad Sci III. 294 (18): 933–8. PMID 6814714
Kolata, Gina (24 de setembro de 1988). «France and China allow sale of a drug for early abortion». The New York Times. p. A1
Greenhouse, Steven (27 de outubro de 1988). «Drug maker stops all distribution of abortion pill». The New York Times. p. A1
Greenhouse, Steven (29 de outubro de 1988). «France ordering company to sell its abortion drug». The New York Times. p. A1
Newman, Barry (22 de fevereiro de 1993). «Drug dilemma: among those wary of abortion pill is maker's parent firm; Germany's Hoechst is facing pressure from Clinton to sell RU-486 in U.S.». The Wall Street Journal. p. A1
«F.D.A. says company delays abortion pill». The New York Times. Associated Press. 16 de abril de 1993. p. A14
Jouzaitis, Carol (17 de outubro de 1994). «Abortion pill battle surprises French firm». Chicago Tribune. p. 1 (Business)
Seelye, Katharine Q. (17 de maio de 1994). «Accord opens way for abortion pill in U.S. in 2 years». The New York Times. p. A1
Kolata, Gina (29 de setembro de 2000). «U.S. approves abortion pill; drug offers more privacy and could reshape debate». The New York Times. p. A1
Moore, Stephen D.; Kamm, Thomas; Fleming, Charles (11 de dezembro de 1996). «Hoechst to seek rest of Roussel-Uclaf; expected $3.04 billion offer would add to the wave of drug-sector linkups». The Wall Street Journal. p. A3
Marshall, Matt (11 de dezembro de 1996). «Hoechst offers to pay $3.6 billion for rest of Roussel». The Wall Street Journal. p. A8
Bloomberg Business News (11 de dezembro de 1996). «Hoechst to buy rest of Roussel». The New York Times. p. D4
Bloomberg News (9 de abril de 1997). «Pill for abortion ends production». The New York Times. p. D2
Jouzaitis, Carol (9 de abril de 1997). «Abortion pill maker bows to boycott heat; German firm gives up RU-486 patent; little impact likely in U.S.». Chicago Tribune. p. 4
Lavin, Douglas (9 de abril de 1997). «Hoechst will stop making abortion pill». The Wall Street Journal. p. A3
(18 de abril de 1997). «Roussel-Uclaf to transfer RU 486 rights». Reprod Freedom News. 6 (7): 8. PMID 12292550
Dorozynski, Alexander (19 de abril de 1997). «Boycott threat forces French company to abandon RU486». BMJ. 314 (7088): 1150. PMC 2126515. PMID 9146386. doi:10.1136/bmj.314.7088.1145m

query.nytimes.com

Suzanne Daley (5 de outubro de 2000). «Europe Finds Abortion Pill is No Magic Cure-All». The New York Times. Consultado em 16 de setembro de 2006
Tamar Lewin (30 de janeiro de 1995). «Clinical Trials Giving Glimpse of Abortion Pill». The New York Times. Consultado em 20 de setembro de 2006
Tamar Lewin (13 de novembro de 1997). «Lawsuits' Settlement Brings New Hope for Abortion Pill». The New York Times. Consultado em 16 de setembro de 2006
Margaret Talbot (11 de julho de 1999). «The Little White Bombshell». The New York Times. Consultado em 20 de setembro de 2006
Gina Kolata (24 de setembro de 2003). «Death at 18 Spurs Debate Over a Pill For Abortion». The New York Times. Consultado em 20 de setembro de 2006
Peter S. Green (24 de junho de 2003). «A Rocky Landfall for a Dutch Abortion Boat». The New York Times. Consultado em 16 de setembro de 2006

oxfordjournals.org

humrep.oxfordjournals.org

Etienne-Emile Baulieu, Daniel S. Seidman, Selma Hajri (outubro de 2001). «Mifepristone(RU-486) and voluntary termination of pregnancy: enigmatic variations or anecdotal religion-based attitudes?». Human Reproduction. Consultado em 16 de setembro de 2006

pqarchiver.com

pqasb.pqarchiver.com

Newman, Barry (22 de fevereiro de 1993). «Drug dilemma: among those wary of abortion pill is maker's parent firm; Germany's Hoechst is facing pressure from Clinton to sell RU-486 in U.S.». The Wall Street Journal. p. A1
«F.D.A. says company delays abortion pill». The New York Times. Associated Press. 16 de abril de 1993. p. A14
Jouzaitis, Carol (17 de outubro de 1994). «Abortion pill battle surprises French firm». Chicago Tribune. p. 1 (Business)
Bloomberg News (9 de abril de 1997). «Pill for abortion ends production». The New York Times. p. D2
Jouzaitis, Carol (9 de abril de 1997). «Abortion pill maker bows to boycott heat; German firm gives up RU-486 patent; little impact likely in U.S.». Chicago Tribune. p. 4
Lavin, Douglas (9 de abril de 1997). «Hoechst will stop making abortion pill». The Wall Street Journal. p. A3
(18 de abril de 1997). «Roussel-Uclaf to transfer RU 486 rights». Reprod Freedom News. 6 (7): 8. PMID 12292550
Dorozynski, Alexander (19 de abril de 1997). «Boycott threat forces French company to abandon RU486». BMJ. 314 (7088): 1150. PMC 2126515. PMID 9146386. doi:10.1136/bmj.314.7088.1145m

rcog.org.uk

RCOG (2004). The Care of Women Requesting Induced Abortion : Evidence-based clinical guideline number 7 (PDF). London: RCOG Press. ISBN 1-904752-06-3. Consultado em 25 de agosto de 2015. Arquivado do original (PDF) em 27 de fevereiro de 2008

sante.gouv.fr

Vilain, Annick (dezembro de 2009). «Voluntary terminations of pregnancies in 2007» (PDF). DREES, Ministry of Health. Consultado em 9 de junho de 2010. Arquivado do original (PDF) em 31 de março de 2010

sfgate.com

Fjerstad, Mary; Trussell, James; Sivin, Irving; Lichtenberg, E. Steve; Cullins, Vanessa (9 de julho de 2009). «Rates of serious infection after changes in regimens for medical abortion» (PDF). New England Journal of Medicine. 361 (2): 145–151. PMC 3568698. PMID 19587339. doi:10.1056/NEJMoa0809146
Allday, Erin (9 de julho de 2009). «Change cuts infections linked to abortion pill». San Francisco Chronicle. p. A1

socialstyrelsen.se

National Board of Health and Welfare, Sweden (12 de maio de 2010). «Induced Abortions 2010» (PDF). National Board of Health and Welfare, Sweden. Consultado em 9 de junho de 2010

usembassy-china.org.cn

«Family planning in China: RU-486, abortion, and population trends». U.S. Embassy Beijing. 2000. Consultado em 14 de setembro de 2006. Arquivado do original em 11 de março de 2002

villagevoice.com

Sharon Lerner (agosto de 2000). «RU Pissed Off Yet?». The Village Voice. Consultado em 16 de setembro de 2006

vt.edu

scholar.lib.vt.edu

«Abortion Foes To Boycott Drugs (Altace) Made By RU-486 Manufacturer». The Virginia Pilot. 8 de julho de 1994. Consultado em 15 de setembro de 2006. Arquivado do original em 20 de fevereiro de 2008

washingtonpost.com

Pan, Philip P. (12 de outubro de 2000). «Chinese to Make RU-486 for U.S.». The Washington Post. Consultado em 22 de agosto de 2006
Jones, Rachel K.; Kooistra, Kathryn (março de 2011). «Abortion incidence and access to services in the United States, 2008» (PDF). Perspect Sex Reprod Health. 43 (1): 41–50. PMID 21388504. doi:10.1363/4304111
Stein, Rob (11 de janeiro de 2011). «Decline in U.S. abortion rate stalls». The Washington Post. p. A3

web.archive.org

Peter Gallagher, Navdeep Malik, James Newham, Allan H Young, Nicol Ferrier, Paul Mackin (2008). «Antiglucocorticoid treatments for mood disorders.». Cochrane Database Syst. Review. doi:10.1002/14651858.CD005168.pub2. Consultado em 25 de agosto de 2015. Arquivado do original em 22 de março de 2015
RCOG (2004). The Care of Women Requesting Induced Abortion : Evidence-based clinical guideline number 7 (PDF). London: RCOG Press. ISBN 1-904752-06-3. Consultado em 25 de agosto de 2015. Arquivado do original (PDF) em 27 de fevereiro de 2008
Healy D (2009). «Mifepristone: an overview for Australian practice». Australian Prescriber. 32 (6): 152–154. Consultado em 25 de agosto de 2015. Arquivado do original em 27 de julho de 2011
«Mifeprex label» (PDF). FDA. 19 de julho de 2005. Consultado em 22 de agosto de 2006. Cópia arquivada (PDF) em 28 de junho de 2006
Danco Laboratories (19 de julho de 2005). «Mifeprex U.S. prescribing information» (PDF). Consultado em 9 de março de 2007. Arquivado do original (PDF) em 7 de janeiro de 2007
(4 de novembro de 2009). «List of mifepristone approval» (PDF). New York: Gynuity Health Projects. Consultado em 25 de agosto de 2015. Arquivado do original (PDF) em 26 de julho de 2011
(4 de novembro de 2009). «Map of mifepristone approval» (PDF). New York: Gynuity Health Projects. Consultado em 11 de junho de 2010. Arquivado do original (PDF) em 26 de julho de 2011
«FDA approval letter for Mifepristone». FDA. 28 de setembro de 2000. Consultado em 16 de setembro de 2006. Cópia arquivada em 29 de agosto de 2006
«Medication Abortion in the United States: Mifepristone Fact Sheet» (PDF). Gynuity Health Projects. 2005
Woodcock, Janet (12 de maio de 2006). «Testimony on RU-486». Committee on Government Reform, House of Representatives. FDA. Consultado em 19 de agosto de 2006. Cópia arquivada em 27 de setembro de 2006
«Catholic and Evangelical students join Muslims in RU-486 fight». Catholic News. 9 de fevereiro de 2006. Consultado em 18 de setembro de 2006. Arquivado do original em 27 de outubro de 2006
«Death Toll Rises to 11 Women». Australians Against RU-486. 2006. Consultado em 20 de setembro de 2006. Arquivado do original em 20 de agosto de 2006
Vilain, Annick (dezembro de 2009). «Voluntary terminations of pregnancies in 2007» (PDF). DREES, Ministry of Health. Consultado em 9 de junho de 2010. Arquivado do original (PDF) em 31 de março de 2010
«FDA Approves Mifepristone for the Termination of Early Pregnancy». FDA press release/U.S. Gov. 2000. Consultado em 27 de abril de 2009. Cópia arquivada em 10 de setembro de 2006
«Marie Stopes International Australia - Medical Abortion». 2010. Consultado em 15 de dezembro de 2010. Arquivado do original em 22 de novembro de 2010
«Abortion pill - RU486 (mifepristone)». Better Health Channel Victoria. Julho de 2010. Consultado em 15 de dezembro de 2010. Arquivado do original em 14 de agosto de 2010
«Family planning in China: RU-486, abortion, and population trends». U.S. Embassy Beijing. 2000. Consultado em 14 de setembro de 2006. Arquivado do original em 11 de março de 2002
«Medical Abortion-Implications for Africa» (PDF). Ipas. 2003. Consultado em 16 de setembro de 2006. Arquivado do original (PDF) em 28 de setembro de 2007
«Mifepristone can be sold only to approved MTP Centres: Rajasthan State HRC». Indian Express Health Care Management. 2000. Consultado em 25 de agosto de 2015. Arquivado do original em 24 de janeiro de 2012

who.int

apps.who.int

«WHO Model List of EssentialMedicines» (PDF). World Health Organization. Outubro de 2013. Consultado em 22 de abril de 2014

wiley.com

onlinelibrary.wiley.com

Peter Gallagher, Navdeep Malik, James Newham, Allan H Young, Nicol Ferrier, Paul Mackin (2008). «Antiglucocorticoid treatments for mood disorders.». Cochrane Database Syst. Review. doi:10.1002/14651858.CD005168.pub2. Consultado em 25 de agosto de 2015. Arquivado do original em 22 de março de 2015

worldcat.org

Baulieu, Étienne-Émile (1985). «RU 486: An antiprogestin steroid with contragestive activity in women». In: Baulieu, Étienne-Émile; Segal, Sheldon J. The antiprogesin steroid RU 486 and human fertility control (Proceedings of a conference on the antiprogestational compound RU 486, held October 23–25, 1984, in Bellagio, Italy). New York: Plenum Press. pp. 1–25. ISBN 0-306-42103-8
Baulieu, Étienne-Émile (1985). «Contragestion by antiprogestin: a new approach to human fertility control». Abortion: medical progress and social implications (Symposium held at the Ciba Foundation, London, 27–29 November 1984). Col: Ciba Foundation Symposium. 115. London: Pitman. pp. 192–210. ISBN 0-272-79815-0. PMID 3849413
Baulieu, Étienne-Émile (1989). «Contragestion with RU 486: a new approach to postovulatory fertility control (from Meet the experts — Antiprogestins, edited by Baulieu, É-É; Proceedings of a meeting held in Rio de Janeiro, Brazil, 27 October 1988)». Acta obstetricia et gynecologica Scandinavica. Supplement. 149: 5–8. ISSN 0300-8835. PMID 2694738
Greenhouse, Steven (12 de fevereiro de 1989). «A new pill, a fierce battle». The New York Times Magazine. p. SM22
Palca J (setembro de 1989). «The pill of choice?». Science. 245 (4924): 1319–23. JSTOR 1704254. PMID 2781280. doi:10.1126/science.2781280
Baulieu EE (setembro de 1989). «Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor». Science. 245 (4924): 1351–7. JSTOR 1704267. PMID 2781282. doi:10.1126/science.2781282
Baulieu EE (outubro de 1989). «The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond». JAMA. 262 (13): 1808–1814. PMID 2674487. doi:10.1001/jama.262.13.1808
Bonner, Staci (julho de 1991). «Drug of choice». SPIN. 7 (4): 55–56, 88. ISSN 0886-3032
Baulieu, Étienne-Émile; Rosenblum, Mort (15 de novembro de 1991). The "abortion pill": RU-486: a woman's choice (translation of: 'Génération pilule). New York: Simon & Schuster. pp. 18, 26–28. ISBN 0-671-73816-X
Beck, Joan (2 de janeiro de 1992). «RU-486 pill adds a new dimension to the abortion debate». Chicago Tribune. p. 25
Chesler, Ellen (31 de julho de 1992). «RU-486: we need prudence, not politics». The New York Times. p. A27
Baulieu, Étienne-Émile (13 de abril de 1993). «1993: RU 486—a decade on today and tomorrow». In: Donaldson, Molla S.; Dorflinger, Laneta; Brown, Sarah S.; Benet, Leslie Z. Clinical applications of mifepristone (RU 486) and other antiprogestins; assessing the science and recommending a research agenda; (Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine). Washington, D.C.: National Academy Press. pp. 71–119. ISBN 0-309-04949-0
Baulieu EE (junho de 1994). «RU486: a compound that gets itself talked about». Hum. Reprod. 9 Suppl 1: 1–6. PMID 7962455. doi:10.1093/humrep/9.suppl_1.1
Baulieu, Étienne-Émile (1997). «Innovative procedures in family planning». In: Johannisson, Elisabeth; Kovács, László; Resch, Bela A; Bruyniks, Nico P. Assessment of research and service needs in reproductive health in Eastern Europe — concerns and commitments. Proceedings of a workshop organized by the ICRR and the WHO Collaborating Centre on Research in Human Reproduction in Szeged, Hungary, 25–27 October 1993. New York: Parthenon Publishing. pp. 51–60. ISBN 1-85070-696-4
(2008). «contragestive». The American Heritage medical dictionary. Boston: Houghton Mifflin. p. 124. ISBN 978-0-618-94725-6
adj. Capable of preventing gestation, either by preventing implantation or by causing the uterine lining to shed after implantation. —n. A contragestive drug or agent.
Ammer, Christine (2009). «contragestive». The encyclopedia of women's health 6th ed. New York: Facts On File. pp. 124–125. ISBN 978-0-8160-7407-5
Also contragestant, abortion pill. A substance called mifepristone, or RU-486, which was developed by Dr. Etienne Baulieu and the Roussel-Uclaf company. The contragestive blocks progesterone receptors in the endometrium (uterine lining), preventing its buildup by progesterone; hence the uterus cannot sustain a pregnancy. It does not prevent fertilization or implantation, so technically it is an ABORTIFACIENT rather than a contraceptive.